The Role of Positron Emission Tomography (PET) in Management of Endocarditis
<p id="p1">Endocarditis is a condition associated with high mortality and still often represents a diagnostic challenge due to the variability of its clinical manifestations. The 2023 ESC Guidelines for the management of endocarditis incorporate, within the modified Duke’s criteria, new imagin...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2025
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/1220197 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | <p id="p1">Endocarditis is a condition associated with high mortality and still often represents a diagnostic challenge due to the variability of its clinical manifestations. The 2023 ESC Guidelines for the management of endocarditis incorporate, within the modified Duke’s criteria, new imaging modalities elaborated and published by the International Society for Cardiovascular Infectious Diseases (ISCVID): 18F-Fluorodeoxyglucose Positron Emission Tomography (18F-FDG-PET)/Cardiac Computed Tomography (CT). This technique combines the advantages of whole-body 18F-FDG-PET with the spatial resolution of CT, offering good sensitivity and specificity (0.74—CI 0.70–0.77 and 0.88—CI 0.86–0.91, respectively) for all cases of endocarditis, with improved performance, particularly in prosthetic valve endocarditis, positioning itself as a promising tool in this field. This chapter aims to review the role of 18F-FDG-PET)/CT in comparison with other imaging techniques, highlighting its potential use as an important diagnostic method in different clinical settings of endocarditis.</p> |
|---|---|
| ISBN: | 978-1-83634-929-7 |
| DOI: | 10.5772/intechopen.1010891 |